Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
35.41
-0.36 (-1.01%)
Sep 17, 2025, 4:00 PM EDT - Market closed
KNSA Market Cap
KNSA has a market cap or net worth of $2.62 billion as of September 17, 2025. Its market cap has increased by 37.64% in one year.
Market Cap
2.62B
Enterprise Value
2.36B
1-Year Change
37.64%
Ranking
Category
Stock Price
$35.41
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $2.62B, an increase of 178.24%. That is a compound annual growth rate of 15.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.65B | 85.61% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.01B |
| Johnson & Johnson | 425.26B |
| AbbVie | 383.25B |
| UnitedHealth Group | 309.32B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 231.15B |